Wainberg ZA, Anghel A, Desai AJ, Ayala R, et al. Editor's Note: Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab In vitro and In vivo. Clin Cancer Res 2026;32:3707.
PMID: 42596724